United States · FDA National Drug Code directory
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70010-189_1cb60a8e-0849-4a3e-e063-6294a90a350e
- Product NDC
- 70010-189
- Form
- TABLET, FILM COATED
- Composition / generic term
- LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
- Labeler
- Granules Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230929
- Source listing expiry
- 20261231
Source-listed ingredients
- LOSARTAN POTASSIUM — 100 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (70010-189-03) · 70010-189-03
- 1000 TABLET, FILM COATED in 1 BOTTLE (70010-189-10) · 70010-189-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →